Hearing loss is an etiologically heterogeneous trait with differences in the age of onset, severity and site of lesion. It is caused by a combination of genetic and/or environmental factors. A longitudinal study to examine the efficacy of early intervention for improving child outcomes is ongoing in Australia. To determine the cause of hearing loss in these children we undertook molecular testing of perinatal “Guthrie” blood spots of children whose hearing loss was either detected via newborn hearing screening or detected later in infancy. We analyzed the GJB2 and SLC26A4 genes for the presence of mutations, screened for the mitochondrial DNA (mtDNA) A1555G mutation, and screened for congenital CMV infection in DNA isolated from dried newborn blood spots. Results were obtained from 364 children. We established etiology for 60% of children. One or two known GJB2 mutations were present in 82 children. Twenty-four children had one or two known SLC26A4 mutations. GJB2 or SLC26A4 changes with unknown consequences on hearing were found in 32 children. The A1555G mutation was found in one child, and CMV infection was detected in 28 children. Auditory neuropathy spectrum disorder was confirmed in 26 children whose DNA evaluations were negative. A secondary objective was to investigate the relationship between etiology and audiological outcomes over the first 3 years of life. Regression analysis was used to investigate the relationship between hearing levels and etiology. Data analysis does not support the existence of differential effects of etiology on degree of hearing loss or on progressiveness of hearing loss.
References
[1]
Davis A, Davis KAS (2011) Chapter 5. Descriptive epidemiology of childhood hearing impairment. In: , editor. Comprehensive Handbook of Pediatric Audiology: Plural Publishing, Abingdon, UK. pp. 85–111.
[2]
Access Economics (2006) Listen Hear. The Economic Impact and Cost of Hearing Loss in Australia.
[3]
Thompson DC, McPhillips H, Davis RL, Lieu TL, Homer CJ, et al. (2001) Universal newborn hearing screening: summary of evidence. JAMA 286: 2000–2010.
[4]
Morton CC, Nance WE (2006) Newborn hearing screening–a silent revolution. N Engl J Med 354: 2151–2164.
[5]
King AC, Parkinson KN, Adamson AJ, Murray L, Besson H, et al. (2011) Correlates of objectively measured physical activity and sedentary behaviour in English children. Eur J Public Health 21: 424–431.
[6]
Vander Werff KR, Prieve BA, Georgantas LM (2009) Infant air and bone conduction tone burst auditory brain stem responses for classification of hearing loss and the relationship to behavioral thresholds. Ear Hear 30: 350–368.
[7]
Barbi M, Binda S, Primache V, Caroppo S, Dido P, et al. (2000) Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol 17: 159–165.
[8]
del Castillo FJ, Rodriguez-Ballesteros M, Alvarez A, Hutchin T, Leonardi E, et al. (2005) A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment. J Med Genet 42: 588–594.
[9]
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nature methods 7: 248–249.
[10]
Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature protocols 4: 1073–1081.
[11]
Sanchez JL, Storch GA (2002) Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol 40: 2381–2386.
[12]
Scanga L, Chaing S, Powell C, Aylsworth AS, Harrell LJ, et al. (2006) Diagnosis of human congenital cytomegalovirus infection by amplification of viral DNA from dried blood spots on perinatal cards. J Mol Diagn 8: 240–245.
[13]
The “R Project for Statistical Computing” website. R Development Core Team. A language and environment for statistical computing (Version 2.13.1). Available: http://www.r-project.org/. Accessed 2012 May 8.
[14]
The “ggplot2: An implementation of the Grammar of Graphics” website. Wickham H and Chang W. Available: http://cran.r-project.org/package=ggplot？2. Accessed 2012 May 8.
[15]
The “nlme: Linear and Nonlinear Mixed Effects Models” website. Pinheiro J, Bates, D., DebRoy, S., Sarkar, D. & R Development Core Team. Available: http://cran.r-project.org/package=nlme. Accessed 2012 May 8.
[16]
Connexin-deafness Homepage website. Ballana E, Ventayol M, Rabionet R, Gasparini P, Estivill X. Available: http://davinci.crg.es/deafness/. Accessed 2012 Aug 26.
[17]
Pendred/BOR Homepage website. Chang E, K？lln KA, Nishimura CJ, Fischer S, Smith RJH. Available: http://www.healthcare.uiowa.edu/labs/pen？dredandbor/. Accessed 2012 Aug 26.
[18]
Deafness Gene Mutation Database website. Harvard Medical School Center for Hereditary Deafness (2012). Available: http://hearing.harvard.edu/genepages/pds？dream.htm. Accessed 2012 Aug 26.
[19]
Australian Hearing website Demographic Details of Persons under the age of 21 years with a Hearing Impairment who are fitted with a Hearing Aid - 2011. Available: http://www.hearing.com.au/digitalAssets/？13809_1352761241226_Demographics%20of%20？Persons%20under%20the%20age%20of%2021%20？years%20with%20Hearing%20Aids.pdf. Accessed 2012 May 8.
Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan RW Jr, et al. (2010) Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. Jama 303: 1375–1382.
[22]
Declau F, Boudewyns A, Van den Ende J, Peeters A, van den Heyning P (2008) Etiologic and audiologic evaluations after universal neonatal hearing screening: analysis of 170 referred neonates. Pediatrics 121: 1119–1126.
[23]
Stehel EK, Shoup AG, Owen KE, Jackson GL, Sendelbach DM, et al. (2008) Newborn hearing screening and detection of congenital cytomegalovirus infection. Pediatrics 121: 970–975.
[24]
Smith RJ, Bale JF Jr, White KR (2005) Sensorineural hearing loss in children. Lancet 365: 879–890.
[25]
Denoyelle F, Weil D, Maw MA, Wilcox SA, Lench NJ, et al. (1997) Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 6: 2173–2177.
[26]
Denoyelle F, Marlin S, Weil D, Moatti L, Chauvin P, et al. (1999) Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet 353: 1298–1303.
[27]
Murgia A, Orzan E, Polli R, Martella M, Vinanzi C, et al. (1999) Cx26 deafness: mutation analysis and clinical variability. J Med Genet 36: 829–832.
[28]
Snoeckx RL, Huygen PL, Feldmann D, Marlin S, Denoyelle F, et al. (2005) GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 77: 945–957.
[29]
Dahl HH, Saunders K, Kelly TM, Osborn AH, Wilcox S, et al. (2001) Prevalence and nature of connexin 26 mutations in children with non-syndromic deafness. Med J Aust 175: 191–194.
[30]
Tekin M, Xia XJ, Erdenetungalag R, Cengiz FB, White TW, et al. (2010) GJB2 mutations in Mongolia: complex alleles, low frequency, and reduced fitness of the deaf. Ann Hum Genet 74: 155–164.
[31]
Cucci RA, Prasad S, Kelley PM, Green GE, Storm K, et al. (2000) The M34T allele variant of connexin 26. Genet Test 4: 335–344.
[32]
Houseman MJ, Ellis LA, Pagnamenta A, Di WL, Rickard S, et al. (2001) Genetic analysis of the connexin-26 M34T variant: identification of genotype M34T/M34T segregating with mild-moderate non-syndromic sensorineural hearing loss. J Med Genet 38: 20–25.
[33]
Kenna MA, Feldman HA, Neault MW, Frangulov A, Wu BL, et al. (2010) Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. Arch Otolaryngol Head Neck Surg 136: 81–87.
[34]
Teek R, Kruustuk K, Zordania R, Joost K, Reimand T, et al. (2010) Prevalence of c.35delG and p.M34T mutations in the GJB2 gene in Estonia. Int J Pediatr Otorhinolaryngol 74: 1007–1012.
[35]
Dahl HH, Tobin SE, Poulakis Z, Rickards FW, Xu X, et al. (2006) The contribution of GJB2 mutations to slight or mild hearing loss in Australian elementary school children. J Med Genet 43: 850–855.
[36]
Palmada M, Schmalisch K, Bohmer C, Schug N, Pfister M, et al. (2006) Loss of function mutations of the GJB2 gene detected in patients with DFNB1-associated hearing impairment. Neurobiol Dis 22: 112–118.
[37]
Thonnissen E, Rabionet R, Arbones ML, Estivill X, Willecke K, et al. (2002) Human connexin26 (GJB2) deafness mutations affect the function of gap junction channels at different levels of protein expression. Hum Genet 111: 190–197.
[38]
Dai P, Yu F, Han B, Liu X, Wang G, et al. (2009) GJB2 mutation spectrum in 2,063 Chinese patients with nonsyndromic hearing impairment. J Transl Med 7: 26.
[39]
Tsukada K, Nishio S, Usami S (2010) A large cohort study of GJB2 mutations in Japanese hearing loss patients. Clin Genet 78: 464–470.
[40]
Han SH, Park HJ, Kang EJ, Ryu JS, Lee A, et al. (2008) Carrier frequency of GJB2 (connexin-26) mutations causing inherited deafness in the Korean population. J Hum Genet 53: 1022–1028.
[41]
Kim HJ, Park CH, Lee KO, Won HH, Ko MH, et al. (2010) Sequence Variations and Haplotypes of the GJB2 Gene Revealed by Resequencing of 192 Chromosomes from the General Population in Korea. Clin Exp Otorhinolaryngol 3: 65–69.
[42]
Mese G, Londin E, Mui R, Brink PR, White TW (2004) Altered gating properties of functional Cx26 mutants associated with recessive non-syndromic hearing loss. Hum Genet 115: 191–199.
[43]
Siemering K, Manji SS, Hutchison WM, Du Sart D, Phelan D, et al.. (2006) Detection of mutations in genes associated with hearing loss using a microarray-based approach. J Mol Diagn 8: 483–489; quiz 528.
[44]
Azaiez H, Yang T, Prasad S, Sorensen JL, Nishimura CJ, et al. (2007) Genotype-phenotype correlations for SLC26A4-related deafness. Hum Genet 122: 451–457.
[45]
Choi BY, Stewart AK, Madeo AC, Pryor SP, Lenhard S, et al. (2009) Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms? Hum Mutat 30: 599–608.
[46]
Albert S, Blons H, Jonard L, Feldmann D, Chauvin P, et al. (2006) SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur J Hum Genet 14: 773–779.
[47]
Blons H, Feldmann D, Duval V, Messaz O, Denoyelle F, et al. (2004) Screening of SLC26A4 (PDS) gene in Pendred’s syndrome: a large spectrum of mutations in France and phenotypic heterogeneity. Clin Genet 66: 333–340.
[48]
Campbell C, Cucci RA, Prasad S, Green GE, Edeal JB, et al. (2001) Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat 17: 403–411.
[49]
Fugazzola L, Cerutti N, Mannavola D, Crino A, Cassio A, et al. (2002) Differential diagnosis between Pendred and pseudo-Pendred syndromes: clinical, radiologic, and molecular studies. Pediatr Res 51: 479–484.
[50]
Pera A, Dossena S, Rodighiero S, Gandia M, Botta G, et al. (2008) Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA. Proc Natl Acad Sci U S A 105: 18608–18613.
[51]
Pryor SP, Madeo AC, Reynolds JC, Sarlis NJ, Arnos KS, et al. (2005) SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet 42: 159–165.
[52]
Yang T, Vidarsson H, Rodrigo-Blomqvist S, Rosengren SS, Enerback S, et al. (2007) Transcriptional Control of SLC26A4 Is Involved in Pendred Syndrome and Nonsyndromic Enlargement of Vestibular Aqueduct (DFNB4). Am J Hum Genet 80: 1055–1063.
[53]
Wang QJ, Zhao YL, Rao SQ, Guo YF, He Y, et al. (2011) Newborn hearing concurrent gene screening can improve care for hearing loss: a study on 14,913 Chinese newborns. Int J Pediatr Otorhinolaryngol 75: 535–542.
